Physician
David L Schneider MD Apmc
David L Schneider MD Apmc was paid $7.05M by Medicaid between Jan 2018 and Dec 2024, across 48 billing codes. Its largest line is 95165, Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials — 17% of everything it billed.
33Billing provider infoDAVID L SCHNEIDER MD APMC
MARRERO, LA 70072
MARRERO, LA 70072
33aNPI1285716886assigned 10/20/2006
33bProvider typeAllergy & Immunology Physician
28Total paid$7.05M
24GClaims101,402
24DCodes billed48
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Allergy & Immunology Physician providers in Louisiana
Rank by total paid#2 of 23
Median peer was paid$247K
This provider vs. median29×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,073 | $389K | |
| 2019 | 10,063 | $458K | |
| 2020 | 9,144 | $461K | |
| 2021 | 9,318 | $564K | |
| 2022 | 9,692 | $628K | |
| 2023 | 31,963 | $2.75M | |
| 2024incomplete | 22,149 | $1.80M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 17% | 5,385 | 2,181 | $1.22M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 11% | 14,588 | 12,224 | $778K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 11% | 3,369 | 3,086 | $770K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 10% | 9,251 | 8,146 | $739K |
| 31231 | 7.6% | 4,087 | 3,431 | $536K | |
| 31237 | 6.4% | 1,217 | 894 | $449K | |
| 86003 | 6.3% | 1,499 | 1,365 | $447K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 6.2% | 5,863 | 4,983 | $435K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 5.5% | 3,174 | 2,861 | $388K |
| 95117 | 4.9% | 32,495 | 14,810 | $345K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.7% | 947 | 765 | $122K |
| 31295 | 1.6% | 133 | 75 | $115K |
36 more codes
| 30140 | 1.6% | 552 | $112K | |
| 95800 | 1.3% | 123 | $95K | |
| 70486 | 1.3% | 855 | $91K | |
| 95115 | 1.1% | 8,453 | $78K | |
| 30117 | 1.1% | 279 | $76K | |
| 31575 | <1% | 417 | $33K | |
| 30469 | <1% | 17 | $23K | |
| 92567 | <1% | 1,559 | $20K | |
| 69210 | <1% | 609 | $17K | |
| 82785 | <1% | 832 | $16K | |
| 96401 | <1% | 320 | $16K | |
| 31255 | <1% | 63 | $15K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 405 | $13K |
| 61782 | <1% | 110 | $12K | |
| 92552 | <1% | 544 | $12K | |
| 92557 | <1% | 297 | $12K | |
| 31525 | <1% | 44 | $9K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 682 | $9K |
| 92511 | <1% | 54 | $8K | |
| J2357 | Injection, omalizumab, 5 mg | <1% | 94 | $7K |
| 92556 | <1% | 208 | $5K | |
| 90674 | <1% | 207 | $5K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 140 | $4K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 28 | $4K |
| 92555 | <1% | 169 | $3K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 132 | $2K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 994 | $2K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 155 | $2K |
| 92550 | <1% | 102 | $2K | |
| 70220 | <1% | 37 | $956.83 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 41 | $843.28 |
| 30801 | <1% | 17 | $832.93 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 757 | $382.94 |
| 92587 | <1% | 14 | $355.92 | |
| 99051 | <1% | 28 | $347.28 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 56 | $253.91 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFATAKIA, ADIL (OWNER)